Diligence memo · auto-generated · as of July 2, 2026
Altay Therapeutics
Altay Therapeutics: limited disclosed financing to assess.
Businessfiled
Altay Therapeutics operates in Biotech, based in San Francisco, CA, USA; South San Francisco, CA, USA. Altay develops disease-modifying therapies targeting transcription…
Sub-sector tags: AI-powered Drug Discovery, Biotech, Drug discovery, Therapeutics, pharma.
Capital & rounds (filed)filed
Altay Therapeutics has raised — in disclosed capital across 0 recorded rounds, aggregated from public filings.
Valuation (modeled)modeled
No modeled valuation — too little disclosed financing to estimate one.
Financing rhythm & timingmixed
Not enough dated financing history to read a financing rhythm.
Comparablesmixed
Capital scale ranks ahead of 67% of Biotech peers (233 compared).
Modeled value ranks above 67% of those peers.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.